Director D

University Overview

The University of Pennsylvania, the largest private employer in Philadelphia, is a world-renowned leader in education, research, and innovation. This historic, Ivy League school consistently ranks among the top 10 universities in the annual U.S. News & World Report survey. Penn has 12 highly-regarded schools that provide opportunities for undergraduate, graduate and continuing education, all influenced by Penn’s distinctive interdisciplinary approach to scholarship and learning. As an employer Penn has been ranked nationally on many occasions with the most recent award from Forbes who named Penn one of America’s Best Large Employers in 2023.

Penn offers a unique working environment within the city of Philadelphia. The University is situated on a beautiful urban campus, with easy access to a range of educational, cultural, and recreational activities. With its historical significance and landmarks, lively cultural offerings, and wide variety of atmospheres, Philadelphia is the perfect place to call home for work and play.

The University offers a competitive benefits package that includes excellent healthcare and tuition benefits for employees and their families, generous retirement benefits, a wide variety of professional development opportunities, supportive work and family benefits, a wealth of health and wellness programs and resources, and much more.

Posted Job Title

Director D

Job Profile Title

Director D, Research

Job Description Summary

The Director of the Bispecific Release by Immune T cells for Engagement (BRITE) program will lead a team focused on the development of CAR T cells engineered to secrete bispecific molecules that engage diverse targets, including tumor-associated antigens, stromal components, tumor-associated macrophages/fibroblasts, NK Cells, and other immune cell subsets. This role supports the Director of the Center for Cellular Immunotherapies (CCI) in overseeing a laboratory division dedicated to integrating cutting-edge technologies, gene delivery systems—such as lipid nanoparticles and other non-viral vectors— and bispecifics into T cell platforms. The Director will also spearhead efforts to implement innovative cell engineering strategies and next-generation immunotherapeutic approaches to enhance antitumor activity and enable clinical translation.

Job Description

Job Responsibilities

• Responsibilities entail the management of a multidisciplinary team, providing guidance and support to postdoctoral researchers, graduate students, and supervising research staff. This involves overseeing research progress and goals, as well as contributing to strategic planning initiatives led by the Director of CCI. Additionally, the Director will be responsible for initiating and overseeing research studies and conducting thorough data analysis. They will ensure the timely planning and execution of projects, including the preparation, review, and approval of reports, presentations, scientific papers, and grant applications. The Director will present data at local, national, and international meetings, monitor progress and timelines related to projects, and provide updates to the Director of CCI.
• Other duties and responsibilities as assigned

Position is contingent upon funding

Qualifications

• Master of Science, 5 to 7 years of experience or equivalent combination of education and experience is required. PhD Preferred
• Expertise and knowledge in cancer immunology and immunotherapy.
• Extensive background in cellular and molecular immunotherapies, T cell- and macrophage-based therapies, CAR-T cells, cell and gene therapy, signaling pathways, checkpoint blockade, immunostimulatory monoclonal antibodies and bispecific molecules, and lipid nanoparticle technology.
• Proficient in macrophage and T-cell biology, multiparametric flow cytometry and sorting, preclinical efficacy assessment (in immune deficient and syngeneic mouse models), in vivo toxicity and biodistribution studies, and local and systemic immunotherapeutic combinations.
• Extensive experience with cell culture methods, viral and non-viral transduction techniques, various gene editing modalities, immunological (proliferation, supp